Relationship of mid-thigh adiposity to the metabolic syndrome in postmenopausal women.
BACKGROUND
In postmenopausal women, a population at risk for the metabolic syndrome, the relative contribution of central fat versus peripheral muscle fat to the metabolic risk profile is unknown. This study explored the relationship between muscle fat infiltration derived from computed tomography (CT) scans and metabolic syndrome.


METHODS
Mid-thigh CT scans measured the surface of muscle with low attenuation (LAMS) [0-34 Hounsfield units (HU)], which represented the specific component of fat-rich muscle. Insulin sensitivity was evaluated by an euglycemic-hyperinsulinemic clamp. National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III) criteria were used to determine the presence of the metabolic syndrome.


RESULTS
A total of 103 postmenopausal women were studied. Metabolic syndrome was found in 43 women with significantly higher levels of abdominal adiposity, higher LAMS (27 +/- 8 vs. 23 +/- 7 cm(2)), and lower insulin sensitivity compared to those without the metabolic syndrome. Women with higher levels of LAMS presented higher metabolic risk features such as higher blood pressure, abdominal adiposity, inflammatory markers, and blood lipid levels. LAMS and visceral adipose tissue correlated significantly with the presence of metabolic syndrome, but these relationships were lost when LAMS was adjusted for visceral adipose tissue but not when visceral adipose tissue was adjusted for LAMS.


CONCLUSIONS
These results suggest that postmenopausal women who present with metabolic syndrome had increased fat-rich mid-thigh muscle. Moreover, women with more fat-rich muscle had many features of the metabolic syndrome. These relations were weakened when visceral adipose tissue was taken into account suggesting that LAMS may play a relatively smaller role, compared to VAT, in the contribution to the metabolic syndrome.
Dubé
M-C
MC
Diabetes Research Unit, CHUL Research Center, Québec, Canada.
Lemieux
S
S
Piché
M-E
ME
Corneau
L
L
Bergeron
J
J
Riou
M-E
ME
Weisnagel
S J
SJ
D050154:Adiposity / Q000502:physiology*; D000368:Aged; D000886:Anthropometry; D015415:Biomarkers / Q000097:blood; D001823:Body Composition / Q000502:physiology; D005260:Female; D015309:Glucose Clamp Technique; D005951:Glucose Tolerance Test; D006439:Hemodynamics; D006801:Humans; D007249:Inflammation / Q000097:blood; D008055:Lipids / Q000097:blood; D008074:Lipoproteins / Q000097:blood; D024821:Metabolic Syndrome / Q000473:pathology*; D008875:Middle Aged; D017698:Postmenopause / Q000502:physiology*; D013848:Thigh / Q000033:anatomy & histology* / Q000473:pathology*; D014057:Tomography, X-Ray Computed
D015415:Biomarkers; D008055:Lipids; D008074:Lipoproteins